170 related articles for article (PubMed ID: 26109117)
1. Randomised controlled trial of topical kanuka honey for the treatment of rosacea.
Braithwaite I; Hunt A; Riley J; Fingleton J; Kocks J; Corin A; Helm C; Sheahan D; Tofield C; Montgomery B; Holliday M; Weatherall M; Beasley R
BMJ Open; 2015 Jun; 5(6):e007651. PubMed ID: 26109117
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial of topical kanuka honey for the treatment of acne.
Semprini A; Braithwaite I; Corin A; Sheahan D; Tofield C; Helm C; Montgomery B; Fingleton J; Weatherall M; Beasley R
BMJ Open; 2016 Feb; 6(2):e009448. PubMed ID: 26832428
[TBL] [Abstract][Full Text] [Related]
3. Protocol for a randomised controlled trial of 90% kanuka honey versus 5% aciclovir for the treatment of herpes simplex labialis in the community setting.
Semprini A; Singer J; Shortt N; Braithwaite I; Beasley R;
BMJ Open; 2017 Aug; 7(8):e017766. PubMed ID: 28775197
[TBL] [Abstract][Full Text] [Related]
4. Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial.
Semprini A; Singer J; Braithwaite I; Shortt N; Thayabaran D; McConnell M; Weatherall M; Beasley R
BMJ Open; 2019 May; 9(5):e026201. PubMed ID: 31092654
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.
Del Rosso JQ
Cutis; 2010 Nov; 86(5 Suppl):16-25. PubMed ID: 21229827
[TBL] [Abstract][Full Text] [Related]
6. Natural Skin Care Products as Adjunctive to Prescription Therapy in Moderate to Severe Rosacea.
Draelos ZD; Gunt H; Levy SB
J Drugs Dermatol; 2019 Feb; 18(2):141-146. PubMed ID: 30794364
[TBL] [Abstract][Full Text] [Related]
7. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
Karabulut AA; Izol Serel B; Eksioglu HM
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of low molecular weight hyaluronic acid sodium salt 0.2% cream in rosacea.
Schlesinger TE; Powell CR
J Drugs Dermatol; 2013 Jun; 12(6):664-7. PubMed ID: 23839183
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of a cream containing modified glutathione (GSH-C4), beta-Glycyrrhetic, and azelaic acids in mild-to-moderate rosacea: A pilot, assessor-blinded, VISIA and ANTERA 3-D analysis, two-center study (The "Rosazel" Trial).
Dall'Oglio F; Puviani M; Milani M; Micali G
J Cosmet Dermatol; 2021 Apr; 20(4):1197-1203. PubMed ID: 32885541
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
Stein L; Kircik L; Fowler J; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Liu H; Jacovella J
J Drugs Dermatol; 2014 Mar; 13(3):316-23. PubMed ID: 24595578
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.
Gold LS; Papp K; Lynde C; Lain E; Gooderham M; Johnson S; Kerrouche N
J Drugs Dermatol; 2017 Sep; 16(9):909-916. PubMed ID: 28915286
[TBL] [Abstract][Full Text] [Related]
12. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
[TBL] [Abstract][Full Text] [Related]
13. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
Baumann L; Goldberg DJ; Stein Gold L; Tanghetti EA; Lain E; Kaufman J; Weng E; Berk DR; Ahluwalia G
J Drugs Dermatol; 2018 Mar; 17(3):290-298. PubMed ID: 29537447
[TBL] [Abstract][Full Text] [Related]
14. A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea.
Mrowietz U; Kedem TH; Keynan R; Eini M; Tamarkin D; Rom D; Shirvan M
Am J Clin Dermatol; 2018 Jun; 19(3):427-436. PubMed ID: 29396702
[TBL] [Abstract][Full Text] [Related]
15. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.
Stein Gold L; Kircik L; Fowler J; Jackson JM; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Sugarman J; Liu H; Jacovella J;
J Drugs Dermatol; 2014 Nov; 13(11):1380-6. PubMed ID: 25607706
[TBL] [Abstract][Full Text] [Related]
16. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.
Taieb A; Ortonne JP; Ruzicka T; Roszkiewicz J; Berth-Jones J; Peirone MH; Jacovella J;
Br J Dermatol; 2015 Apr; 172(4):1103-10. PubMed ID: 25228137
[TBL] [Abstract][Full Text] [Related]
17. An open-label, community-based, 12-week assessment of the effectiveness and safety of monotherapy with doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads).
Webster GF
Cutis; 2010 Nov; 86(5 Suppl):7-15. PubMed ID: 21229826
[TBL] [Abstract][Full Text] [Related]
18. Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial.
Lee DH; Li K; Suh DH
Br J Dermatol; 2008 May; 158(5):1069-76. PubMed ID: 18363758
[TBL] [Abstract][Full Text] [Related]
19. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
Chu CY
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
[TBL] [Abstract][Full Text] [Related]
20. Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study.
Schaller M; Dirschka T; Kemény L; Briantais P; Jacovella J
Dermatol Ther (Heidelb); 2016 Sep; 6(3):427-36. PubMed ID: 27432169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
